CRL
Charles River Laboratories
Description:
Charles River Laboratories International, Inc. (CRL) is a premier global provider of essential products and services tailored for the pharmaceutical, biotechnology, and medical device sectors. The company offers a comprehensive suite of preclinical and clinical laboratory services, including advanced gene and cell therapy solutions that enhance research and development capabilities. With a strong commitment to innovation and strict compliance with regulatory standards, Charles River is instrumental in streamlining drug development processes, ultimately driving advancements in healthcare solutions worldwide.
Industry:
DIAGNOSTICS & RESEARCH
Address:
251 BALLARDVALE STREET, WILMINGTON, MA, UNITED STATES, 01887
Fiscal year end:
December
Market capitalization:
$10.6 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+148%
How much will you get:
$2,481
Prices dates:
31-12-2015: $80.39 and 31-12-2025: $199.48